Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 1
1980 1
1981 1
1982 1
1987 1
1988 1
1990 5
1991 1
1992 3
1993 2
1994 4
1995 5
1997 2
1998 1
1999 2
2000 2
2002 3
2003 3
2004 4
2005 2
2006 5
2007 3
2008 5
2009 5
2010 6
2011 2
2012 1
2013 1
2014 1
2015 4
2016 4
2017 6
2018 6
2019 3
2020 2
2021 4
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, Stea B, Yoon H, Li J, Laack NN, Kruser TJ, Chmura SJ, Shi W, Deshmukh S, Mehta MP, Kachnic LA; for NRG Oncology. Brown PD, et al. Among authors: stea b. J Clin Oncol. 2020 Apr 1;38(10):1019-1029. doi: 10.1200/JCO.19.02767. Epub 2020 Feb 14. J Clin Oncol. 2020. PMID: 32058845 Free PMC article. Clinical Trial.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Brachytherapy for Central Serous Chorioretinopathy.
Arora S, Stea BD, Hamilton RJ, Chhablani J. Arora S, et al. Among authors: stea bd. Ophthalmol Ther. 2022 Oct;11(5):1611-1616. doi: 10.1007/s40123-022-00543-6. Epub 2022 Jul 6. Ophthalmol Ther. 2022. PMID: 35793036 Free PMC article.
Vulvar carcinoma.
Anderson JM, Cassady JR, Shimm DS, Stea B. Anderson JM, et al. Among authors: stea b. Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1351-7. doi: 10.1016/0360-3016(95)00090-L. Int J Radiat Oncol Biol Phys. 1995. PMID: 7635775
Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme.
Lickliter JD, Ruben J, Kichenadasse G, Jennens R, Gzell C, Mason RP, Zhou H, Becker J, Unger E, Stea B. Lickliter JD, et al. Among authors: stea b. Cancer Res Commun. 2023 Aug 21;3(8):1607-1614. doi: 10.1158/2767-9764.CRC-22-0433. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37609003 Free PMC article.
102 results